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We measured Ca 2+ uptake by sarcoplasmic reticulum prepared from left ventricular myocardium obtained from six nonfailing human hearts and nine excised hearts from patients with class IV idiopathic dilated cardiomyopathy. Ca 2+ uptake had a V mu of 593 ±82 nmol/mg-min, a KOJ of 0.68±0.07 /JLM, and an n^ of 1.7±0.1 in the nonfailing hearts. The corresponding values in the excised failing hearts were 593±36 nmol/mg-min, 0.63±0.03 fiM, and 1.6±0.1. The 0-receptor density in crude sarcolemma prepared from left ventricular myocardium was 110.0±15.3 fmol/mg in the unmatched donors and 52.1±4.5 fmol/mg in the excised failing hearts. These results suggest that abnormal Ca 2+ handling in idiopathic dilated cardiomyopathy in humans is not the result of any intrinsic alteration of Ca 2+ uptake by sarcoplasmic reticulum. R elaxation in mammalian cardiac myocytes is believed to result primarily from the sequestration of free Ca 2+ from the cytosol by the Ca 2+ -transporting ATPase of sarcoplasmic reticulum membranes (for review, see Movsesian 1 ) . A reduction in Ca 2+ uptake by sarcoplasmic reticulum might therefore be expected to result in impairment of myocardial relaxation.
Whether diminished Ca 2+ uptake by sarcoplasmic reticulum contributes to the pathophysiology of heart failure in humans is unknown. Left ventricular relaxation has been shown to be abnormal in congestive cardiomyopathy in humans, and the rate of decline of intracellular [Ca 2+ ] is diminished in muscle from failing heart. 2 -3 Furthermore, in several studies involving animal models of cardiac hypertrophy and failure, Ca 2+ uptake rates and capacities of cardiac sarcoplasmic reticulum vesicles have been shown to be diminished. 4 -" Recently, Ca 2+ uptake rates were reported to be diminished by 50% in homogenates of right ventricular biopsy specimens obtained from patients with heart failure. 12 These observations raise the possibility that Ca 2+ uptake by sarcoplasmic reticulum is impaired in heart failure in humans.
To test this possibility, we compared Ca 2+ uptake by sarcoplasmic reticulum in vesicle preparations from left ventricular myocardial tissue obtained from normal unmatched donors and from heart transplant recipients with idiopathic dilated cardiomyopathy.
Materials and Methods

Human Specimens
Nonfailing left ventricular tissue was obtained through the UTAH Cardiac Transplant Program from kidney donors with normal cardiac function by echocardiography for whom no suitable recipients were available. The donor population comprised persons aged 8 to 62years (mean, 37.3±8.5) with no evidence of cardiac disease who had suffered traumarelated brain death and had been maintained on respirators for 2 to 5 days before tissue procurement. Failing left ventricular tissue was obtained from the excised hearts of transplant recipients aged 21 to 61 years (mean 48.9±4.7, probability nonsignificant vs. nonfailing) with class IV idiopathic dilated cardiomyopathy.
Hearts were excised after infusion of cold cardioplegia solution into the roots of the crossclamped aortas and maintained at 4° C until preparation of sarcoplasmic reticulum and sarcolemma. The time between cardiac excision and homogenization was less than 2.5 hours with hearts procured at distant locations and less than 0.5 hours with hearts procured locally.
Preparation of Cardiac Sarcoplasmic Reticulum
Sarcoplasmic reticulum was prepared by homogenizing tissue from left ventricular free wall (two 10-second cycles in a Kinematica GmbH homogenizer, setting 10) in 5 volumes of 0.29 M sucrose, 3 mM NaN 3 , 1 mM dithiothreitol (DTT), and 10 mM [A^-morpholino]propanesulfonic acid (MOPS) (pH 7.0, 4° C) ("sucrose buffer"), to which were added 2 mM ethylenegycol bis(/3-aminoethyl ether) N,N,N',JV'-tetraacetic acid (EGTA), 0.1 ^M pepstatin and 0.8 mM phenylmethylsulfonyl fluoride. After two 10-minute sedimentations at 8,000 rpm in a Beckman JA-20 rotor (Fullerton, California), the supernatant was sedimented for 60 minutes at 19,000 rpm in a Beckman 55.2 Ti rotor. The resulting pellet was resuspended by hand homogenization (glassglass) in 2 volumes (relative to starting material) of 0.6 M KC1, 3 mM NaN 3 , 1 mM DTT, and 10 mM MOPS (pH 6.8, 4° C). After resedimentation for 40 minutes at 37,000 rpm in a Beckman T865 rotor, the pellet was suspended in sucrose buffer and stored at -80° C until use.
Calcium Uptake
The procedure was modified from our published method. 13 Vesicles prepared as described were suspended at 0.10 mg/ml in 0.102 M KC1, 5.05 mM MgCl 2 ,1.0 mM EGTA, 5.0 mM oxalic acid, 5.0 mM NaN 3 , and 20 mM MOPS (pH 7.05, 37° C) ("uptake buffer"). ^CaC^ was added as appropriate to yield free [Ca 2+ ]s from 0.1 /xM to 50.0 fjM, calculated using published dissociation constants 14 ; the free [Mg 2 *] was 0.4 mM. Ca 2+ uptake was initiated by addition of 5.0 mM ATP. Aliquots were removed at four intervals over a time course throughout which uptake was linear (2-8 minutes depending on [Ca 2+ ]) and were filtered and washed six times with 2.0 ml of 0.12 M KCl/2.0 mM EGTA under vacuum through 25-mm paper filter disks (pore size, 0.22 fim). ^Ca adherent to filter disks (i.e., taken up by the vesicles) was determined by scintillation spectrometry. Uptake was normalized relative to vesicle protein determined by Bradford's method. 15 Uptake rates (v) were calculated by least-squares linear regression analysis (r^0.98 in all cases) of four time points. Each uptake rate used in the calculations described below was the mean±SEM of five or more uptake measurements. V^,, was calculated using a double- ] at which log v /(Vm«x-v)=0 is KOJ; the first derivative of the second-order polynomial at this point is^-
Receptor Density in Cardiac Sarcolemma
Crude myocardial sarcolemma was prepared from left ventricular free wall as described previously and was stored in 250 mM sucrose, 1 mM EGTA, and 50 mM Tris (pH 7.5, 4° C) at a protein concentration of 5-10 mg/ml at -80° C until use.
1 '' fiReceptor density in these preparations was calculated according to a previously published method using (-)-[
12S I]iodocyanopindolol (ICYP). 18 Assays were conducted in 150 mM NaCl, 1 mM ascorbate, and 20 mM Tris (pH 7.5, 30° C). The protein concentration varied between 33 and 169 mg/ml (average 123±12 mg/ml). Maximum binding ( B^) was determined by nonlinear least-squares fit of the specific binding curve. Seven increasing concentrations of ICYP between 3.125 and 150 or 200 pM in the presence and absence of 1 M (-)-propranolol were used to construct the specific binding isotherm. In all assays performed, specific binding of ICYP was ^90% of total binding at low (<6 pM) radioligand concentrations. In calculating binding parameters, ICYP was assumed to undergo molecular decomposition into non-/3-receptor active products in direct relation to radioactive decay.
Phospholipid Determination
Lipids were extracted from isolated sarcoplasmic reticulum preparations by the method of Bligh and Dyer. 19 The total phospholipid contents of the extracts were quantified by the method of Chen et al 20 and were normalized to the protein contents of the samples.
Results
We measured Ca 2+ uptake in sarcoplasmic reticulum prepared from left ventricular myocardium of nonfailing hearts and end-stage failing hearts ( Table  1 ). The yield of sarcoplasmic reticulum was 0.42±0.04 mg/g of starting material from excised failing hearts and 0.35 ±0.03 from normal donors. We found no significant differences between normal hearts and excised failing hearts with respect to V m « (593±82 vs. 593±36 nmol/mg-min), Ko 5 (0.68±0.07 vs. 0.63+0.03 fiM), or n^ (1.7±0.1 vs. ) .60.1). Our inability to detect any differences in Ca 2+ uptake by sarcoplasmic reticulum from nonfailing and failing hearts made it important to ensure that the nonfailing left ventricular myocardial tissue used in our experiments was in fact "normal." To do this, we measured )3-receptor densities in sarcolemmal preparations from the left ventricular tissue used in our Ca 2+ uptake experiments ( Table  2 ). The /3-receptor density in sarcolemma prepared from unmatched donor hearts was 110.0±15.3 fmol/ rag protein, which falls within the normal range reported for nonfailing human left ventricular myocardium. 17 - 19 In contrast, sarcolemma prepared from excised failing hearts had a /9-receptor density of 52.1 ±4.5 fmol/mg, consistent with reported val- ues in failing human left ventricular myocardium. Reflecting these differences, the ratio of ^-receptor density to maximal Ca 2+ uptake was 0.20±0.04 in unmatched donors and 0.09±0.01 in explanted failing hearts.
It was also important to ensure that the sarcoplasmic reticulum preparations from nonfailing and failing hearts comprised similar membrane fractions. For this reason, we measured the phospholipid/ protein ratios in sarcoplasmic reticulum prepared from normal and failing hearts. The ratio (nanomoles phosphate per milligram protein) was 35.3±4.0 in the normal hearts and 34.1±2.4 in the failing hearts.
Discussion
The experiments we describe in this report were undertaken to determine whether the decreased Ca 2+ uptake reported in homogenized myocardium from patients with idiopathic dilated cardiomyopathy resulted from a decrease in specific Ca 2+ uptake activity in sarcoplasmic reticulum. We were unable to detect a decrease in any of the parameters of Ca 2+ uptake examined.
The reasons for the difference between our results in purified sarcoplasmic reticulum and previously reported results in homogenized myocardium are not immediately obvious. In the studies involving homogenized myocardium, Ca 2+ uptake was measured only at high [Ca 2+ ] (5-10 /iM). V,^, K 0J , and nHiu were not determined, so that bases for comparison between the two reports are limited. It is possible that the differences reflect properties of the tissue studied. Biopsy specimens used to prepare homogenates were obtained from right ventricular myocardium, whereas vesicle preparations used in our experiments were derived from the left ventricular myocardium. Insofar as the diagnosis of heart failure in both studies was based on alterations in left ventricular function, however, we would have expected left ventricular tissue to have been affected at least as much as right ventricular tissue. Another possibility is that the specific Ca 2+ uptake activity of sarcoplasmic reticulum might not be affected in heart failure, but the amount of sarcoplasmic reticulum per cell might be diminished. Our finding that the yield of sarcoplasmic reticulum relative to tissue weight was higher in failing than nonfailing heart makes this unlikely. We cannot, however, exclude the possibility that right ventricular endomyocardial tissue, from which biopsy specimens were obtained, is somehow uniquely affected in terms of the amount of sarcoplasmic reticulum per cell. It is also possible that the intracellular distribution of sarcoplasmic reticulum relative to the contractile elements is altered in heart failure, and this could conceivably contribute to abnormal Ca 2+ handling.
Ca 2+ uptake might be affected by factors, either intrinsic or extrinsic to the sarcoplasmic reticulum, that are present in cell homogenates but absent from microsomal preparations. Phospholamban phosphorylation, for example, has been shown to stimulate Ca 2+ uptake by cardiac sarcoplasmic reticulum from other mammalian species (see Movsesian 1 ), and the level of phosphorylation might be significantly lower in failing heart due to decreased /3-adrenergic receptor density. If phospholamban remained phosphorylated in crude homogenates but was dephosphorylated during the preparation of vesicles, effects on Ca 2+ uptake would have been lost when measurements were made in the latter. We are currently engaged in experiments designed to examine this possibility.
Finally, we wish to emphasize that our conclusions are based solely on experiments involving myocardial tissue from patients with heart failure due to idiopathic dilated cardiomyopathy and should not be extended to other forms of heart disease, such as restrictive, hypertrophic, or ischemic cardiomyopathy.
